QCG
ANGO icon

Quadrant Capital Group’s AngioDynamics ANGO Stock Holding History

Quadrant Capital Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Sell
791
-103
-12% -$1.12K ﹤0.01% 2217
2025
Q4 		$11.5K Sell
894
-18
-2% -$222 ﹤0.01% 2170
2025
Q3 		$10.2K Buy
+912
New +$8.8K ﹤0.01% 2154
2025
Q2 		– Sell
-958
Closed -$9K – 1397
2025
Q1 		$9K Buy
+958
New +$10.1K ﹤0.01% 2237
2023
Q4 		– Sell
-308
Closed -$2.25K – 2697
2023
Q3 		$2.25K Sell
308
-513
-62% -$4.27K ﹤0.01% 2359
2023
Q2 		$8.56K Buy
821
+657
+401% +$6.32K ﹤0.01% 2062
2023
Q1 		$1.7K Sell
164
-1
-0.6% -$13 ﹤0.01% 2457
2022
Q4 		$2.27K Buy
165
+18
+12% +$250 ﹤0.01% 2378
2022
Q3 		$3K Hold
147
– – ﹤0.01% 2249
2022
Q2 		$3K Hold
147
– – ﹤0.01% 2085
2022
Q1 		$3K Hold
147
– – ﹤0.01% 2028
2021
Q4 		$4K Hold
147
– – ﹤0.01% 1934
2021
Q3 		$4K Hold
147
– – ﹤0.01% 1916
2021
Q2 		$4K Hold
147
– – ﹤0.01% 1894
2021
Q1 		$3K Hold
147
– – ﹤0.01% 1930
2020
Q4 		$2K Hold
147
– – ﹤0.01% 1911
2020
Q3 		$2K Buy
147
+15
+11% +$142 ﹤0.01% 1787
2020
Q2 		$1K Sell
132
-46
-26% -$474 ﹤0.01% 2005
2020
Q1 		$1K Buy
+178
New +$2.23K ﹤0.01% 1949

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Quadrant Capital Group's ANGO Position: Q1 2026 in Review

Quadrant Capital Group reduced its AngioDynamics (ANGO) stake by 12% in Q1 2026, selling an estimated $1.12K and leaving 791 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Quadrant Capital Group first reported a position in ANGO in Q1 2020 and has held it in 19 quarters since. The position peaked at $11.5K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Quadrant Capital Group held 791 shares of AngioDynamics worth $9K as of Q1 2026.
  • Quadrant Capital Group sold 103 AngioDynamics shares in Q1 2026, an estimated $1.12K.
  • AngioDynamics made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2217 holding.
  • Quadrant Capital Group first reported a position in AngioDynamics in Q1 2020 and has held it in 19 quarters since.
  • Quadrant Capital Group's AngioDynamics position peaked at $11.5K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.